Equivalence of dimensional reduction and dimensional regularisation

For some years there has been uncertainty over whether regularisation by dimensional reduction (DRED) is viable for non-supersymmetric theories. We resolve this issue by showing that DRED is entirely equivalent to standard dimensional regularisation (DREG), to all orders in perturbation theory and for a general renormalisable theory. The two regularisation schemes are related by an analytic redefinition of the couplings, under which the -functions calculated using DRED transform into those computed in DREG. TheS-matrix calculated using DRED is numerically equal to the DREG version, ensuring that both schemes give the same physics.     

Sessions of the Seminar “Algebra i Logika”

Sessions of the seminar algebra i logika     

Collinear quantum mechanical probabilities and rate constants for the Br + HCl(ν = 2, 3, 4) reaction using hyperspherical coordinates

Calculations of quantum mechanical probabilities and rate constants for the collinear reaction Br + HCl(ν = 2,3,4) → BrH + Cl, Br + HCl(ν < ν) were performed using hyperspherical coordinates. Removal of vibrationally excited HCl proceeds mainly by reaction to a nearly degenerate HBr state. Processes for which a large change in the internal enery occurs have low probabilities.     

Nonpeptide inhibitors of cathepsin G: optimization of a novel beta-ketophosphonic acid lead by structure-based drug design

The serine protease cathepsin G (EC 3.4.21.20; Cat G), which is stored in the azurophilic granules of neutrophils (polymorphonuclear leukocytes) and released on degranulation, has been implicated in various pathological conditions associated with inflammation. By employing high-throughput screening, we identified beta-ketophosphonic acid 1 as a moderate inhibitor of Cat G (IC(50) = 4.1 microM). We were fortunate to obtain a cocrystal of 1 with Cat G and solve its structure by X-ray crystallography (3.5 A). Structural details from the X-ray analysis of 1.Cat G served as a platform for optimization of this lead compound by structure-based drug design. With the aid of molecular modeling, substituents were attached to the 3-position of the 2-naphthyl ring of 1, which occupies the S1 pocket of Cat G, to provide an extension into the hydrophobic S3 region. Thus, we arrived at analogue 7 with an 80-fold potency improvement over 1 (IC(50) = 53 nM). From these results, it is evident that the beta-ketophosphonic acid unit can form the basis for a novel class of serine protease inhibitors.